Latest update: 17 March

Many economists have cut their GDP forecasts. The 2021 consensus forecast for GDP growth is currently negative and many predict a recession.

The UK economy contracted by 2.9% in December 2020 when compared with the previous month over renewed lockdown measures.


Vaccine rollout and massive US stimulus has lifted world economic prospects, with the OECD projecting global economic growth at 5.6% for 2021.


According to the OECD, unemployment rate in OECD nations stood at 6.8% in Jan 2021, unchanged from the previous month but down from 7.5% recorded in August 2020.

Impact of Covid-19 on equity indices


Latest update: 04 March

financial impact and relief


The ophthalmic viscoelastic devices market suffered revenue losses of 17.3% in 2020, as the market largely depends on cataract and glaucoma surgeries. 


Estimates suggest that over 90% of neuromodulation procedures performed in the US are elective. As a result, almost all neuromodulation procedures were delayed in the initial lockdowns.

General surgery devices 

Currently, the market for robotic surgical systems used in general surgery is dominated by Intuitive Surgical, with its da Vinci Robotic System. However, an increase in market competitiveness is imminent, with Medtronic developing its Hugo Robotic Assisted Surgery (RAS) System. 

According to GlobalData’s Robotic Surgical Systems market analysis, the market value of Robotic Surgical Systems in the US in 2020 was negatively impacted by over 18% due to the Covid-19 crisis, making this market unfavorable towards the marketing of new robotic surgical systems.

With many elective general surgical procedures having resumed at near pre-pandemic levels in Q4 2020, and as sales of new systems is expected to undergo a surge period in 2021 by nearly 46% in the US alone, GlobalData expects the marketing of the Hugo RAS System potentially within H1 2021 to be welltimed.

Key Medical device market developments

Dental devices

Dental devices will benefit from declining Covid-19 rates and successful Covid-19 vaccinations. However, dental devices are not expected to recover as quickly as other medical device markets.

According to the latest surveys from the American Dental Association, more dental practices are reporting that they are open and operating with business as usual.

For three months, dental practices have been regaining normal patient volumes. There are fewer shortages of personal protective equipment among dental practices, but there is a shortage of gowns in 7% of practices. More than 65% of practices have more than 14 days’ worth of PPE. 

Neurology devices

GlobalData valued the global neuromodulation market at $4.9bn in 2019, and it was expected to accelerate in 2020.

However, the Covid-19 pandemic severely impacted the neuromodulation market, with a global market value of $4bn in 2020.

Due to vaccinations and public health efforts, the market is expected to see a recovery in growth during 2021, with revenues of $5.7bn expected in 2021.

Share this article